OptiPin
MK-777 (Acetamoren): uses, dosing & the facts
A next-generation oral growth hormone secretagogue optimized from MK-677. Features enhanced receptor selectivity and pharmacokinetics with 92% greater affinity to GHS-R1a receptor. This is an evidence-graded reference – what it is, what it's used for, typical reported dosing, half-life, side effects, and how to track it. It is educational, not medical advice or a recommendation to use a research compound.
- • MK-777 (Acetamoren) – Oral GH secretagogue. A next-generation oral growth hormone secretagogue optimized from MK-677.
- • Commonly used for enhanced muscle growth without hunger stimulation, improved sleep architecture (deeper rem), bone density enhancement.
- • Half-life: Approximately 8–10 hours.
- • Status: Research use only · not FDA-approved – an educational reference, not a dose protocol or sourcing advice.
What MK-777 (Acetamoren) is
A next-generation oral growth hormone secretagogue optimized from MK-677. Features enhanced receptor selectivity and pharmacokinetics with 92% greater affinity to GHS-R1a receptor.
What MK-777 (Acetamoren) is used for
- • Enhanced muscle growth without hunger stimulation
- • Improved sleep architecture (deeper REM)
- • Bone density enhancement
- • Tissue-selective IGF-1 activation (muscle over visceral fat)
- • Growth hormone stimulation without injections
- • Convenience of oral administration with superior profile
These are reported/community uses, not proven clinical outcomes. Most research peptides have limited human trial data behind such claims.
Typical reported dosing
| Oral | 10–30mg per day, taken orally once daily, typically before bed |
Presented as commonly-reported patterns for information only – not a dose recommendation. MK-777 (Acetamoren) dosing is a decision for a qualified clinician.
Half-life & cycling
Half-life: Approximately 8–10 hours. Half-life drives dosing frequency and how quickly the compound clears – see it plotted on the MK-777 (Acetamoren) half-life calculator.
Cycling
Can be used for extended periods. Typical cycles: 6–12 months. Some use continuously.
Side effects & warnings
- an injection site that turns red, hot or hard, spreads, weeps, or comes with a fever – same-day medical care – research-grade material carries no sterility guarantee, so abscess and cellulitis are the documented consequence
- swelling of the lips, tongue or throat, trouble breathing, or widespread hives after a dose – emergency care
- new numbness or tingling in the hands, or hands and ankles that stay swollen – stop and get assessed – these are the classic signs of too much growth hormone signalling
- unusual thirst, or passing much more urine than normal – a blood-glucose check, since GH secretagogues raise it
- • Reduced appetite stimulation compared to MK-677
- • Minimal lethargy
- • No cortisol level disruption
- • No glucose homeostasis disruption
- • Generally well-tolerated
68% less hunger stimulation than MK-677. No cortisol or glucose disruption. Superior to MK-677 with longer half-life (8–10 hours vs 4–6 hours). Enhanced receptor affinity. Not a true peptide.
Tracking MK-777 (Acetamoren) in OptiPin
If you're tracking a MK-777 (Acetamoren) protocol, OptiPin logs each dose with reminders and site rotation, charts the outcome you care about over your dose timeline, keeps per-vial inventory with runout warnings, and (where relevant) does the reconstitution math – all on-device, no account.
Log doses, outcomes & vials in OptiPin
Reminders, outcome-over-dose charts, vial runout warnings, and built-in reconstitution math – all on-device.
Download on the App StoreFAQ
What is MK-777 (Acetamoren)?
A next-generation oral growth hormone secretagogue optimized from MK-677. Features enhanced receptor selectivity and pharmacokinetics with 92% greater affinity to GHS-R1a receptor.
What is MK-777 (Acetamoren) used for?
Commonly discussed uses include: enhanced muscle growth without hunger stimulation, improved sleep architecture (deeper rem), bone density enhancement, tissue-selective igf-1 activation (muscle over visceral fat), growth hormone stimulation without injections, convenience of oral administration with superior profile. These are reported uses, not proven outcomes or a recommendation.
How is MK-777 (Acetamoren) dosed?
Commonly reported dosing: Oral – 10–30mg per day, taken orally once daily, typically before bed. This reflects patterns discussed in the community and is presented for information only, not as a dose recommendation – MK-777 (Acetamoren) is not an approved medicine and dosing should involve a qualified clinician.
What is MK-777 (Acetamoren)'s half-life?
Approximately 8–10 hours. Half-life shapes how often it is dosed and how quickly it clears.
What are MK-777 (Acetamoren)'s side effects?
Reported effects include: reduced appetite stimulation compared to mk-677, minimal lethargy, no cortisol level disruption, no glucose homeostasis disruption, generally well-tolerated. Because it is a research compound, its safety profile is not fully characterized; discuss risks with a clinician.
Evidence & further reading
- Search the peer-reviewed literature for MK-777 (Acetamoren) on PubMed (entry point to the primary evidence base, not a specific citation).
- MK-777 (Acetamoren) on ClinicalTrials.gov – registered human trials, if any.
- US FDA / 503A compounding status of research peptides (2026).
- OptiPin peptides guide – categories, evidence grading, and how to run a protocol honestly.
Related
Sermorelin · HGH (Somatropin) · Thymosin Alpha-1 · Wolverine · BPC-157 · TB-500 · Reconstitution calculator · All peptides